A First-of-a-Kind Gene Therapy Cure Has Struggled to Find a Market – MIT Technology Review
MIT Technology Review |
A First-of-a-Kind Gene Therapy Cure Has Struggled to Find a Market
MIT Technology Review GSK's decision to offload Strimvelis, as well as two other experimental gene therapies that have not yet been approved, highlights how challenging it has been to market complex, ultra-costly genetic treatments designed to help tiny groups of patients. GSK gives up on rare diseases as gene therapy gets two customers |
